Current Clinical Trials


Palmetto Retina - Wednesday, March 21, 2018

BOULEVARD-BP30099: A multiple-center, multiple-dose, randomized, active comparator−controlled, double-masked, parallel group, 28-week study to investigate the safety, tolerability, pharmacokinetics, and efficacy of ro6867461 administered intravitreally in patients with Diabetic Macular Edema

LADDER-GX28228: A phase II, multicenter, randomized, active treatment−controlled study of the efficacy and safety of the Ranibizumab port delivery system for sustained delivery of Ranibizumab in patients with subfoveal Neovascular Age-Related Macular Degeneration

OMASPECT-GX30191: A multicenter, open-label extension study to evaluate the long-term safety and tolerability of Lampalizumab in patients with geographic atrophy secondary to Age-Related Macular Degeneration who have completed a Roche-sponsored study

SPECTRI-GX29185: A Phase III, Multicenter, Randomized, Double-Masked, Sham - Controlled Study To Assess The Efficacy And Safety of Lampalizumab Administered Intravitreally To Patients with Geographic Atrophy Secondary To Age-Related Macular Degeneration

PROXIMA A- GX 29633: A multicenter, prospective epidemiologic study of the progression of Geographic Atrophy secondary to Age−Related Macular Degeneration

TREX DME- A phase I/II, open-label, multicenter, randomized, controlled study of the safety, tolerability and efficacy of intravitreal injections of 0.3 milligram Ranibizumab given monthly compared to a TReat and EXtend protocol, with and without laser photocoagulation, in patients with Diabetic Macular Edema

Trackback Link
Post has no trackbacks.


Combined Years of Practice


Operations Performed


Clinical Trials Participated



Our Physicians

Take a few moments to meet the skilled physicians of Palmetto Retina, P.A.

Please Contact Us For More Information

(803) 931-0077 | (888) 931-0077